Role of a DNA damage checkpoint pathway in ionizing radiation-induced glioblastoma cell migration and invasion

Cellular and Molecular Neurobiology

Volumn 32, Issue 7, 2012, Pages 1199-1208

  Vanan, Issai ^a,b,c   Dong, Zhiwan ^a,d   Tosti, Elena ^a,e   Warshaw, Gregg ^a,f   Symons, Marc ^a,b   Ruggieri, Rosamaria ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b Northwell Health   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

Cell cycle arrest; Checkpoint; Glioblastoma; Invasion; Migration

Indexed keywords

CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; DNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NIBRIN; PROTEIN TYROSINE PHOSPHATASE; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DNA DAMAGE CHECKPOINT; DOWN REGULATION; ENZYME ACTIVATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; INHIBITION KINETICS; IONIZING RADIATION; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL MOVEMENT; DNA DAMAGE; GLIOBLASTOMA; HUMANS; NEOPLASM INVASIVENESS; RADIATION, IONIZING;

EID: 84867581593     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-012-9846-y     Document Type: Article

References (42)

1. Ader I, Delmas C, Bonnet J, Rochaix P, Favre G, Toulas C, Cohen- Jonathan-Moyal E (2003) Inhibition of Rho pathways induces radiosensitization and oxygenation in human glioblastoma xenografts. Oncogene 22:8861-8869
2. Anderson VE, Walton MI, Eve PD, Boxall KJ, Antoni L, Caldwell JJ, Aherne W, Pearl LH, Oliver AW, Collins I, Garrett MD (2011) CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors. Cancer Res 71:463-472
3. Ashwell S, Janetka JW, Zabludoff S (2008) Keeping checkpoint kinases in line: new selective inhibitors in clinical trials. Expert Opin Investig Drugs 17:1331-1340
4. Badiga AV, Chetty C, Kesanakurti D, Are D, Gujrati M, Klopfenstein JD, Dinh DH, Rao JS (2011) MMP-2 siRNA inhibits radiationenhanced invasiveness in glioma cells. PLoS ONE 6:e20614
5. Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3:421-429
6. Besson A, Dowdy SF, Roberts JM (2008) CDK inhibitors: cell cycle regulators and beyond. Dev Cell 14:159-169
7. Bolderson E, Richard DJ, Zhou BB, Khanna KK (2009) Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res 15:6314-6320
8. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS (2001) Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 61:2207-2211
9. Cheng JC, Chou CH, Kuo ML, Hsieh CY (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25:7009-7018
10. Evdokimova V, Tognon C, Ng T, Sorensen PH (2009) Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1. Cell Cycle 8:2901-2906
11. Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J (2001) The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410:842-847
12. Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME (1996) Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67:275-282
13. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624-1636
14. Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, De Lay M, Van Brocklyn J, Ostrowski MC, Chiocca EA, Lawler SE (2010) MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell 37:620-632
15. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551
16. Gotoh I, Adachi M, Nishida E (2001) Identification and characterization of a novel MAP kinase kinase kinase, MLTK. J Biol Chem 276:4276-4286
17. Gross EA, Callow MG, Waldbaum L, Thomas S, Ruggieri R (2002) MRK, a mixed lineage kinase-related molecule that plays a role in gamma-radiation-induced cell cycle arrest. J Biol Chem 277:13873-13882
18. Hess CF, Schaaf JC, Kortmann RD, Schabet M, Bamberg M (1994) Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 30:146-149
19. Imbach P, Capraro HG, Furet P, Mett H, Meyer T, Zimmermann J (1999) 2,6,9-Trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors. Bioorg Med Chem Lett 9:91-96
20. Jung JW, Hwang SY, Hwang JS, Oh ES, Park S, Han IO (2007) Ionising radiation induces changes associated with epithelialmesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. Eur J Cancer 43:1214-1224
21. Jungmichel S, Stucki M (2010) MDC1: the art of keeping things in focus. Chromosoma 119:337-349
22. Li Z, Jiao X, Wang C, Ju X, Lu Y, Yuan L, Lisanti MP, Katiyar S, Pestell RG (2006) Cyclin D1 induction of cellular migration requires p27(KIP1). Cancer Res 66:9986-9994
23. Liu TC, Huang CJ, Chu YC, Wei CC, Chou CC, Chou MY, Chou CK, Yang JJ (2000) Cloning and expression of ZAK, a mixed lineage kinase-like protein containing a leucine-zipper and a sterilealpha motif. Biochem Biophys Res Commun 274:811-816
24. Marcu LG (2010) Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain. Cancer Treat Rev 36:606-614
25. McClellan KA, Ruzhynsky VA, Douda DN, Vanderluit JL, Ferguson KL, Chen D, Bremner R, Park DS, Leone G, Slack RS (2007) Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions. Mol Cell Biol 27:4825-4843
26. Monferran S, Skuli N, Delmas C, Favre G, Bonnet J, Cohen-Jonathan- Moyal E, Toulas C (2008) Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int J Cancer 123:357-364
27. Nirmala C, Jasti SL, Sawaya R, Kyritsis AP, Konduri SD, Ali-Osman F, Rao JS, Mohanam S (2000) Effects of radiation on the levels of MMP-2, MMP-9 and TIMP-1 during morphogenic glial- endothelial cell interactions. Int J Cancer 88:766-771
28. Niyazi M, Siefert A, Schwarz SB, Ganswindt U, Kreth FW, Tonn JC, Belka C (2011) Therapeutic options for recurrent malignant glioma. Radiother Oncol 98:1-14
29. Ohuchida K, Mizumoto K, Murakami M, Qian LW, Sato N, Nagai E, Matsumoto K, Nakamura T, Tanaka M (2004) Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64: 3215-3222
30. Park CM, Park MJ, Kwak HJ, Lee HC, Kim MS, Lee SH, Park IC, Rhee CH, Hong SI (2006) Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/ Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res 66:8511-8519
31. Petrini JH, Stracker TH (2003) The cellular response to DNA doublestrand breaks: defining the sensors and mediators. Trends Cell Biol 13:458-462
32. Qian LW, Mizumoto K, Urashima T, Nagai E, Maehara N, Sato N, Nakajima M, Tanaka M (2002) Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 8:1223-1227
33. Shapiro GI, Harper JW (1999) Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest 104:1645-1653
34. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP (2005) MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123:1213-1226
35. Tosti E, Waldbaum L, Warshaw G, Gross EA, Ruggieri R (2004) The stress kinase MRK contributes to regulation of DNA damage checkpoints through a p38gamma-independent pathway. J Biol Chem 279:47652-47660
36. Valerie K, Yacoub A, Hagan MP, Curiel DT, Fisher PB, Grant S, Dent P (2007) Radiation-induced cell signaling: inside-out and outside-in. Mol Cancer Ther 6:789-801
37. Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725-1731
38. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329
39. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W (2001) Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61:2744-2750
40. Zhai GG, Malhotra R, Delaney M, Latham D, Nestler U, Zhang M, Mukherjee N, Song Q, Robe P, Chakravarti A (2006) Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway. J Neurooncol 76: 227-237
41. Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestell RG, Quong JN, Quong AA (2010) Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. Cancer Res 70:2105-2114
42. Zhou BB, Elledge SJ (2000) The DNA damage response: putting checkpoints in perspective. Nature 408:433-439